Sona Nanotech Awards Stock Options and Advances Cancer Therapy
Company Announcements

Sona Nanotech Awards Stock Options and Advances Cancer Therapy

Story Highlights

Sona Nanotech Inc (TSE:SONA) has released an update.

Sona Nanotech Inc. has awarded 25,000 stock options to a consultant, with a vested interest accruing every six months and an exercise price of $0.30 per share. Simultaneously, the company is advancing its innovative Targeted Hyperthermia cancer therapy, which employs gold nanoparticles for effective tumor treatment and is moving towards regulatory approvals.

For further insights into TSE:SONA stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Canadian Auto-Generated NewsdeskSona Nanotech Advances Cancer Therapy Research
TipRanks Canadian Auto-Generated NewsdeskSona Nanotech Secures Patent and Strengthens Leadership
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App